Φορτώνει......
Contribution of antibody-mediated effector functions to the mechanism of efficacy of vaccines for opioid use disorders.
Vaccines and monoclonal antibodies (mAb) offer promising strategies to treat substance use disorders (SUD) and prevent overdose. Despite vaccines and mAb against SUD demonstrating proof of efficacy, selectivity, and safety in animal models, it is unknown whether the mechanism of action of these immu...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Immunol |
|---|---|
| Κύριοι συγγραφείς: | , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2021
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8324535/ https://ncbi.nlm.nih.gov/pubmed/34281999 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.2100204 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|